DexCom, Inc. (DXCM) closed at $83.34 on November 14, 2026, a gain of 2.39% on the session. The move added to a strong week for the medical device company, which has now advanced 4.96% over the past seven days.
Despite the recent momentum, the stock remains nearly flat on a longer time horizon, posting a 30-day change of -0.18%. That marginal decline suggests the latest gains have largely recovered ground lost earlier in the month.
DexCom's market capitalization stood at $30.35 billion as of the close, reflecting the company's standing as a major player in the diabetes technology sector. The stock's near-term trajectory has turned positive even as the broader 30-day performance remains essentially unchanged.



